Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.
Clicks: 295
ID: 14770
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
64.5
/100
295 views
236 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Generation of induced pluripotent stem cells (iPSCs) from human peripheral blood provides a convenient and low-invasive way to obtain patient-specific iPSCs. The episomal vector is one of the best approaches for reprogramming somatic cells to pluripotent status because of its simplicity and affordability. However, the efficiency of episomal vector reprogramming of adult peripheral blood cells is relatively low compared with cord blood and bone marrow cells.In the present study, integration-free human iPSCs derived from peripheral blood were established via episomal technology. We optimized mononuclear cell isolation and cultivation, episomal vector promoters, and a combination of transcriptional factors to improve reprogramming efficiency.Here, we improved the generation efficiency of integration-free iPSCs from human peripheral blood mononuclear cells by optimizing the method of isolating mononuclear cells from peripheral blood, by modifying the integration of culture medium, and by adjusting the duration of culture time and the combination of different episomal vectors.With this optimized protocol, a valuable asset for banking patient-specific iPSCs has been established.Reference Key |
gu2018optimizingstem
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Gu, Haihui;Huang, Xia;Xu, Jing;Song, Lili;Liu, Shuping;Zhang, Xiao-Bing;Yuan, Weiping;Li, Yanxin; |
Journal | stem cell research & therapy |
Year | 2018 |
DOI | 10.1186/s13287-018-0908-z |
URL | |
Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.